This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, H.-J. Articles by Tilly, J. L. Search for Related Content PubMed PubMed Citation Articles by Lee, H.-J. Articles by Tilly, J. L. Related Articles Related Editorial

Bone Marrow Transplantation Generates Immature Oocytes and Rescues Long-Term Fertility in a Preclinical Mouse Model of Chemotherapy-Induced Premature Ovarian Failure

Ho-Joon Lee, Kaisa Selesniemi, Yuichi Niikura, Teruko Niikura, Rachael Klein, David M. Dombkowski, Jonathan L. Tilly

From the Vincent Center for Reproductive Biology and Center for Regenerative Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, MA

Address reprint requests to Jonathan L. Tilly, PhD, Massachusetts General Hospital, THR-901B, 55 Fruit St, Boston, MA 02114; e-mail: jtilly{at}partners.org

Purpose: Although early menopause frequently occurs in female cancer patients after chemotherapy (CTx), bone marrow (BM) transplantation (BMT) has been linked to an unexplained return of ovarian function and fertility in some survivors. Studies modeling this in mice have shown that BMT generates donor-derived oocytes in CTx-treated recipients. However, a subsequent report claimed that ovulated eggs are not derived from BM and that BM-derived oocytes reported previously are misidentified immune cells. This study was conducted to further clarify the impact of BMT on female reproductive function after CTx using a preclinical mouse model.

Methods: Female mice were administered CTx followed by BMT using coat color-mismatched female donors. After housing with males, the number of pregnancies and offspring genotype were recorded. For cell tracking, BM from germline-specific green fluorescent protein-transgenic mice was transplanted into CTx-treated wild-type recipients. Immune cells were sorted from blood and analyzed for germline markers.

Results: BMT rescued long-term fertility in CTx-treated females, but all offspring were derived from the recipient germline. Cell tracking showed that donor-derived oocytes were generated in ovaries of recipients after BMT, and two lines of evidence dispelled the claim that these oocytes are misidentified immune cells.

Conclusion: These data from a preclinical mouse model validate a testable clinical strategy for preserving or resurrecting ovarian function and fertility in female cancer patients after CTx, thus aligning with recommendations of the 2005 National Cancer Institute Breast Cancer Progress Review Group and President's Cancer Panel to prioritize research efforts aimed at improving the quality of life in cancer survivors.

Supported by Grant No. R37-AG012279 from the National Institutes of Health, Sea Breeze Foundation, JM Foundation, and Vincent Memorial Research Funds.

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Related Editorial

• Regeneration of Oocytes After Chemotherapy: Connecting the Evidence From Mouse to Human
  Kutluk Oktay and Ozgur Oktem
  JCO 2007 25: 3185-3187 [Full Text]

This article has been cited by other articles:

				S. Begum, V.E. Papaioannou, and R.G. Gosden The oocyte population is not renewed in transplanted or irradiated adult ovaries Hum. Reprod., July 1, 2008; (2008) den249v1. [Abstract] [Full Text] [PDF]

				O. OKTEM and K. OKTAY Stem Cells: A Perspective on Oocytes Ann. N.Y. Acad. Sci., April 1, 2008; 1127(1): 20 - 26. [Abstract] [Full Text] [PDF]

				K. Oktay and O. Oktem Regeneration of Oocytes After Chemotherapy: Connecting the Evidence From Mouse to Human J. Clin. Oncol., August 1, 2007; 25(22): 3185 - 3187. [Full Text] [PDF]